| miRNA | Function | Putative targets | Reference |
| miR-126* | Upregulation leads to chromosomal translocations and inhibits apoptosis | ADAT2,FOF1, LMO7, | [64] |
| miR-126 | Targets tumour suppressor PLK2 | TOM1, CKMT2, ZNF131, RGS3, | [64] |
| miR-223 | C/EBPα regulates its expression in turn it inhibits E2F1 in AML cells | ANKH, SCN1A, SCN3A, CBFB, CDH11, NEBL, RILPL1, CENPN | [65] |
| miR-221 | Oncogenic miRNA, it inhibits the CDK inhibitor p27 | HIPK1, RAB18, DNM3, ZNF547, | [66] |
| miR-124a | Target the C/EBPα, silenced and block differentiation gives leukemia phenotype | | [67] |
| miR-20a and miR-17 | Inhibits the p21 | POLQ, KLF12, STK38, CENTD1, NUP35, GNB5, CTSK | [68] |
| miR-29b | Tumour suppressor in AML and reduce tumorigenicity | SCML2, C1orf96, COL3A1, COL7A1, COL11A1 | [69] |
| miR-29b | Reduced expression of DNA methyltransferases | CD93, HBP1, SNX21, GNS, HMGCR, HNF4G, DNMT3B | [69] |
| miR-196a and miR-196b | They target ERG expression | FOS, GATA6, HOXB6, HOXC8, ZNF24, CCDC47 | [70] |
| miR-193b | Downregulated in AML and it targets c-Kit | MMP19, ARMC1, ARPC5
| [71] |
|
|